Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
Authors
Keywords
-
Journal
LEUKEMIA
Volume 26, Issue 3, Pages 381-389
Publisher
Springer Nature
Online
2011-09-02
DOI
10.1038/leu.2011.234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes
- (2011) Lewis R. Silverman et al. CANCER
- Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) M. F. Fey et al. ANNALS OF ONCOLOGY
- Myelodysplastic Syndromes
- (2010) Bart L. Scott et al. Annual Review of Medicine
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, Acute Leukemias, and Myelodysplastic Syndromes
- (2010) Nicolaus Kröger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
- (2010) J. Choi et al. BLOOD
- Towards individualized follow-up in adult acute myeloid leukemia in remission
- (2010) P. Hokland et al. BLOOD
- Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
- (2010) O. Goodyear et al. BLOOD
- Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome
- (2010) Marcos de Lima et al. CANCER
- Assessment of minimal residual disease in acute myeloid leukemia
- (2010) David Grimwade et al. CURRENT OPINION IN ONCOLOGY
- Relapse after Allogeneic Hematopoietic Cell Therapy
- (2009) Marcel R.M. van den Brink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia
- (2009) Elias Jabbour et al. CANCER
- Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
- (2009) M. Bornhauser et al. HAEMATOLOGICA
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Use of Epigenetic Modification to Induce FOXP3 Expression in Naïve T Cells
- (2009) C. Moon et al. TRANSPLANTATION PROCEEDINGS
- Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
- (2008) U Bacher et al. BONE MARROW TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now